InvestorsHub Logo
Followers 4
Posts 222
Boards Moderated 0
Alias Born 12/20/2011

Re: Cowboy5 post# 176669

Wednesday, 03/29/2017 11:19:06 AM

Wednesday, March 29, 2017 11:19:06 AM

Post# of 402726
I believe you succinctly stated a reasonable position in your original post, however, I believe D has equally valid points. The "shock and awe" of all the hit pieces including Mako's, AF's never ending tweets, the Rosen suit combined with constant bashing and FUD on this and other message boards and the serious losses associated with the dramatic price decline related to the above has had the combined effect of scaring the hell out of retail investors.
The Co.'s market cap is trading at 1/3 of the potential value of K's approval from the FDA for it's Orphan Drug treatment of retinoblastoma, which affords the opportunity to apply for a "Rare Pediatric Disease Review" Voucher which can be sold and in fact have been sold for hundreds of millions of dollars.
This does not include the potential value of B's use as a treatment for biofilm infections in prosthetic orthopedic infections. Orthopedic infection continues to receive a high level of attention, due to the fact that nearly 1 million total hip and knee arthroplasties are performed in the USA each year, and this number is expected to rise in the near term with the aging population. The market is giving no credit to these adjunct applications and little to no value to B,P and K platforms combined.
I'ts clear that retail investors, currently the only holders (not including insiders) are scared to death and are sitting on their wallets until the price action supports their thesis for holding CTIX as an investment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News